Part 1: The Myths and the Science
1: DIAGNOSIS AND CLASSIFICATION
2: CLINICAL FEATURES
3: COMORBIDITY
4: EPIDEMIOLOGY AND LONGITUDINAL COURSE
5: AETIOLOGY
6: SCHIZOPHRENIA AS A BRAIN DISEASE
Part 2: Treatments
7: MODELS OF CARE
8: THE ROLE OF MEDICATION
9: PSYCHOLOGICAL AND PSYCHOSOCIAL TREATMENTS
10: SPECIAL CLINICAL SITUATIONS
Part 3: INFORMATION FOR PATIENTS AND CARERS.
11: MEDICATION AS PART OF THE TREATMENT OF SCHIZOPHRENIA:
INFORMATION FOR PATIENTS AND CARERS
12: COMMON MEDICATIONS IN PSYCHIATRY
13: ANTIPSYCHOTIC MEDICATIONS
14: CLOZAPINE
15: LOOKING AFTER YOUR PHYSICAL HEALTH
Highly commended at the BMA Medical Book Awards 2015
Professor David J Castle MBChB MSc MD FRCPsych FRANZCP is the Chair
of psychiatry at St Vincent's Mental Health and The University of
Melbourne, Australia. He has extensive clinical and research
experience across a wide array of psychiatric issues. In the area
of schizophrenia, he has published widely on aspects as diverse as
epidemiology, aetiology, gender differences, the role of substance
use, and pharmacological and psychosocial treatments. He has
published 12
books, including the British Medical Association Mental Health Book
of the Year for 2005, "Marijuana and Madness " (co-edited with Prof
Robin Murray, Institute of Psychiatry, London). Prof. Peter F.
Buckley, MD, is the Dean of the Medical College of Georgia at
Georgia Regents University in Augusta, Georgia, USA. Dr. Buckley
completed his medical degree, residency in psychiatry, and
schizophrenia fellowship at University College Dublin, School of
Medicine in Ireland. His career in psychiatry has focused on the
many aspects of schizophrenia, including treatment strategies and
the management of treatment refractory schizophrenia, brain
imaging, and the pharmacological management of comorbid
conditions such as depression, substance abuse, and aggression.
`Schizophrenia is a key psychiatric illness, which raises
challenges for diagnosis, assessment and treatment. Given the
prevalence and difficulty in treating schizophrenia, this forms an
essential contribution to the Oxford Psychiatry Library series.
[Do you think this would make a useful contribution to the
literature?] Yes - this would provide a reference for different
aspects of schizophrenia important to medical students and the
practicing clinician.
There is currently much interest in novel treatments for
schizophrenia including CBT and these appear to be covered in this
volume as well as important information on symptoms, diagnosis and
special populations. The section on co-mordity I believe it also
essential, given the practical problems in treatment of this group
and also very recent and compelling evidence concerning the role of
substance misuse.'
Dr Catherine Harmer, University Department of Psychiatry, Warneford
Hospital, Oxford, UK
`Everyone knows of David Castle and he is very well respected... He
has a very comprehensive knowledge of schizophrenia.
'
Dr Philip D. Harvey, Professor of Psychiatry and Behavioral
Sciences, Emory University School of Medicine, Atlanta, USA
|
Ask a Question About this Product More... |
|
